@lungcancerprofiles.com
Read tips and resources for biomarker testing and your non-small cell lung cancer (NSCLC) plan.
๐ข
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
With a comprehensive range of treatment approaches, they aim to provide effective solutions for patients with NSCLC. The brand offers a variety of treatment options, including surgery, radiofrequency ablation (RFA), radiation therapy, chemotherapy, biomarker-driven therapy, and immunotherapy. These approaches are carefully tailored to each individual's needs and cancer condition.
Surgery is often recommended for localized cancers in the early stages, while RFA is a suitable option for small lung tumors located near the outer edge of the lungs. Radiation therapy can be administered externally or internally, depending on the circumstances. Chemotherapy, delivered through anti-cancer drugs, is particularly effective for cancers that have spread throughout the body.
Thanks to advancements in genetics, biomarker-driven therapy enables doctors to customize treatment plans based on the genetic makeup of the tumor. Additionally, immunotherapy stimulates the body's immune system to recognize and destroy cancer cells
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere ๐
All services online
Top brand categories